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Bionics (the imitation or abstraction of the “inventions” of nature) and, to an even greater extent, syn-
thetic biology, will be as relevant to engineering development and industry as the silicon chip was over 
the last 50 years. Chemical industries already use so-called “white biotechnology” for new processes, 
new raw materials, and more sustainable use of resources. Synthetic biology is also used for the devel-
opment of second-generation biofuels and for harvesting the sun’s energy with the help of tailor-made 
microorganisms or biometrically designed catalysts. The market potential for bionics in medicine, en-
gineering processes, and DNA storage is huge. “Moonshot” projects are already aggressively focusing on 
diseases and new materials, and a US-led competition is currently underway with the aim of creating 
a thousand new molecules. This article describes a timeline that starts with current projects and then 
moves on to code engineering projects and their implications, artificial DNA, signaling molecules, and 
biological circuitry. Beyond these projects, one of the next frontiers in bionics is the design of synthetic 
metabolisms that include artificial food chains and foods, and the bioengineering of raw materials; all 
of which will lead to new insights into biological principles. Bioengineering will be an innovation motor 
just as digitalization is today. This article discusses pertinent examples of bioengineering, particularly 
the use of alternative carbon-based biofuels and the techniques and perils of cell modification. Big data, 
analytics, and massive storage are important factors in this next frontier. Although synthetic biology will 
be as pervasive and transformative in the next 50 years as digitization and the Internet are today, its ap-
plications and impacts are still in nascent stages. This article provides a general taxonomy in which the 
development of bioengineering is classified in five stages (DNA analysis, bio-circuits, minimal genomes, 
protocells, xenobiology) from the familiar to the unknown, with implications for safety and security, in-
dustrial development, and the development of bioengineering and biotechnology as an interdisciplinary 
field. Ethical issues and the importance of a public debate about the consequences of bionics and syn-
thetic biology are discussed. 
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1. Another paradigm shift
Industry 4.0 and similar concepts, such as Make in China 2025 
or Digital Industries, are all still incompletely defined and await-
ing more development before they become an industrial reality. 
These concepts and their implementation have followed a well-
known path: Initially limited in scope, they became hugely en-
larged after some time, as the political, academic, consulting, and 
finally enterprise communities latched onto them and re-inter-
preted them to suit their own agendas. Practical considerations 
were addressed by dozens of essentially similar books that mixed 
the original limited concepts with digital disintermediation the-
ory and practice, and included high use of the word “transfor-
mation” in word counts. However, these concepts have not yet 
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deeply impacted the business models and shop floors of success-
ful German and Chinese companies. Courses and programs to 
help companies implement these changes are now widespread. 
Predictably, public debates have begun on what Industry 4.0 and 
related concepts mean for societal change and, particularly, for 
jobs. The public appear to have shifted their attitude from indif-
ference to mistrust, as April 2016 findings by the German Allens-
bach Institute show.
Cloaked at first as fairly harmless debates (often among hu-
man resources (HR) departments and unions) under headings 
such as “Industry 4.0 and the Future of Work,” an alarmist variant 
of these debates now suggests that, at least in richer societies, we 
should immediately take action and provide everybody with a ba-
sic government-supplied income to prepare for the day when ro-
bots do all the work and essentially take over. Concrete figures for 
such a condition-less basic income are already being discussed.
This article explores at first bionics (the imitation or abstrac-
tion of the “inventions” of nature) and then focuses on synthetic 
biology—which, this author insists, will be as relevant to engi-
neering development and industry as the silicon chip was during 
the last 50 years [1,2]. While concepts such as smart cities and 
Industry 4.0 shine a spotlight on the process states enabled by 
digital/Web-based technologies, the changes brought about by 
synthetic biology are more fundamental and foreshadow a tec-
tonic, disruptive, and even geostrategic shift: Industry 5.0.
What have we learned from previous industrial transforma-
tions? Will our experiences help us to handle Industry 5.0 better, 
or will the transitions from one industrial paradigm to the next 
continue to be destructive, brutal, and socially upsetting? This 
author’s action research with several industries, including Ger-
many’s premier industry, the automotive and mobility industry, 
indicates that the implications of these fields are still inadequate-
ly understood and hardly anticipated in strategic plans.
2. Bionics
Bionics is a conceptual precursor to synthetic biology. In bio-
nics, we try to imitate structures and processes created by evo-
lution that we consider to be useful or from which we hope to 
learn. Bionics is a multidisciplinary field that involves scientists, 
engineers, architects, philosophers, and designers. Based on 
their various insights, we systematically investigate how nature 
has successfully solved a problem; then we attempt to copy or 
redesign the process or object under study in a manner that is 
divorced from nature. Bionics has branched off into many special-
ized fields, including construction bionics, sensor bionics, struc-
tural bionics, dynamic bionics, neurobionics, building bionics, 
process bionics, climate bionics, anthropobionics/robotics, and 
evolution bionics [3].
When classifying the astonishing inventions of nature that 
are imitated in bionics, a distinction is made between analogies 
in processes or products, and abstractions. Examples of analo-
gies include airplanes, spiroid winglets, new car tire profiles that 
are modeled on cats’ paws, and spiderlike robots with autono-
mous legs. Examples of abstractions include the lotus effect for 
self-cleaning surfaces, building elements that are modeled like 
trees or bones, riblet foils to reduce friction (in imitation of shark-
skin), and Velcro (in imitation of burrs). Other examples of ab-
stractions include swarm intelligence and ant algorithms, which 
create ant-like autonomous system behaviors (sometimes with 
ant-like robots, as showcased recently at the 2016 Hanover Fair). 
3. Bioeconomy
The so-called bioeconomy is not the focus of this contribu-
tion. However, a brief mention should be made of the concept of 
bioeconomy, in order to delineate it from synthetic biology. For 
example, Germany has established a National Research Strategy 
BioEconomy 2030 with five priority fields of action: global food 
security, sustainable agricultural production, healthy and safe 
foods, the industrial application of renewable resources, and the 
development of biomass-based energy carriers. The general idea 
is to position Germany as a dynamic research and innovation 
center for bio-based products, energy, processes, and services. 
Research is supposed to meet responsibilities for global nutrition, 
as well as for the protection of the climate, resources, and the 
environment. Numerous pillars of German bioeconomy research, 
such as the Helmholtz Association of German Research Centers 
(HGF), which include plant, environmental, geological, climate, 
biotechnology, and engineering research; the Max Planck Society 
(MPS) in life sciences; more than a dozen institutes in the Gott-
fried Wilhelm Leibniz (WGL) science community; and institutes 
within the Fraunhofer Society (FhG) have all pooled their resourc-
es to establish a broad research environment. Over 30 000 scien-
tists in Germany are currently pursuing biotechnical questions 
and issues across more than 200 research facilities, which include 
63 universities, 26 technical colleges, 104 non-university research 
institutes, and nine government-affiliated sites.
4. White biotechnology
White biotechnology, also called industrial biotechnology, ap-
plies science to living organisms and their products. In contrast to 
synthetic biotechnologies, white biotechnology uses the existing 
biodiversity of nature in order to establish industrial processes, 
which are often linked to expectations of ecologically beneficial 
effects. White biotechnology has old roots; humans have used liv-
ing microorganisms in the production of breads, cheeses, beers, 
and wines for centuries. Today, enzymes and microorganisms are 
contained in many everyday items, ranging from detergents to 
creams, and including high-value chemicals, drugs, and vitamins; 
they are also used in textiles, paper and leather production, and 
the production of antibiotics. White biotechnology has strong 
links with bionics; for example, in the use of enzymes, the re- 
creation of spider silk with the help of bacteria, and the produc-
tion of highly elastic rubbers from plants other than rubber trees. 
It encompasses many disciplines, including the bio-sciences, 
chemistry, physics, information science, and the engineering 
sciences. The research landscape of white biotechnology typically 
consists of institutes in collaborating clusters.
5. Synthetic biology
Synthetic biology dramatically shortens the time required for 
evolution to occur [2,4]. In German popular newspaper headlines, 
this engineering science has been variously labeled “Tailor-made 
Life,” “Lego of Life,” “Life from Nothing,” and, ominously, “Remedy 
and Horror.” The field attracts more and more attention; Oxford 
University Press announced a journal devoted to it in April 2016. 
In Germany, the Biotechnology 2020+ project (www.biotechnol-
ogie2020plus.de) brings together the major research institutions 
and networks in this field.
Synthetic biology is an attempt to reshape creation, and is 
part of a long tradition [3]. Wheat fields, for example, are not a 
natural phenomenon, but a human artefact. As scientists, we are 
continuously developing our understanding of the artificial. The 
nanoscale world of cellular building blocks is awe-inspiringly 
complex, and would be impossible to access without modern 
computers, data analytics, and vast storage capabilities. One 
important discipline of synthetic biology, DNA sequencing and 
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in the creation of “genome vessels” by Craig Venter and his team 
(the latter innovation, which was publicized in March 2016, cost 
a paltry 60 million dollars) open up the perspective of targeting 
synthetic drugs directly at affected tissue, without the usual side 
effects to the whole human system. Proteins on a chip will serve 
as sensors in diagnostics. New biomaterials can be created as 
implants, bone replacements, or as dialysis minilabs, if not as out-
right kidneys. Industrial enzymes will help to replace fossil oil-
based chemical processes with biological processes. New minimal 
organisms will emerge as building blocks for a new biological 
diversity. Bio-machines will turn straw into biofuel, and will cap-
ture carbon dioxide from the atmosphere. Our artificial evolution 
will create living, surviving artificial cells and new biological spe-
cies.
5.3. Artificial nucleoid acid structures
The challenge lies in the programming of biological cells to 
create artificial cells with new functions, or cell-like structures 
called bioreactors. If we can reprogram the behavior of organisms, 
we might be able to deploy nanotechnologies to create totally 
new sensors, nano factories, and nano production lines; we could 
use nano containers that liberate their contents when triggered 
by the environment. Nano switches also seem possible.
However, DNA itself is determined and influenced by a com-
plex environment of proteins, lipids, and polysaccharides, and 
much work needs to be done to fully understand these interrela-
tionships.
5.4. Biological sensors and toggle switches
We already use signal molecules in medical diagnostics, for 
example as so-called markers indicating early stages of illnesses. 
Synthetic biology will enable us to build very small toggle switch-
es needing only a small amount of memory. New oscillometers, 
spectrometers, and other intelligent measurement devices will 
emerge from new types of biology-based signaling, including 
very small devices for immediate, instant, and personal use, with 
enough intelligence within the device or in the cloud to provide 
actionable advice—or even to take action and issue alerts when 
necessary. The switching mechanisms will have yet another func-
tion: They will switch off resistance to certain types of drugs, 
such as the antibiotics resistance of certain tuberculosis bacteria.
DARPA is currently coordinating an active competition calling 
for the creation of a thousand new molecules. How much “toy 
biol ogy,” that is, amateur activity, will these capabilities create?
5.5. The extremes of synthetic biology
Synthetic biology keeps the dream of everlasting data storage 
alive; digital data can be encoded onto strands of synthetic DNA.
In space, synthetic biology is expected to free astronauts from 
previous payload restrictions by allowing processes that can 
evolve over time and provide a synthetic environment of superior 
quality.
5.6. Creation of new metabolisms and biofuels
The creation of new food chains is one of the urgent challenges 
of synthetic biology; for example, the sustainable use of raw ma-
terials with the help of biotechnical processes [7]. In some cases, 
this will involve the genetic removal of toxic inhibitors, or the 
production of new combinations for new aromas and tastes. This 
premise goes far beyond artificial meat into strange yet exciting 
possibilities [8].
synthesis, follows Moore’s law and develops exponentially: While 
the first genome cost billions of dollars to sequence, an individual 
genetic test now costs only a thousand dollars and is expected 
to decrease in cost to just a few cents by 2022. The six years be-
tween now and then will likely see the equivalent of more than 
half a century of development and engineering advances, com-
pared with past development.
5.1. The look and “feel” of synthetic biology
What is the look and “feel” of synthetic biology? Examples 
are more illustrative than lengthy abstract descriptions. Here are 
some examples that already exist, or that indicate the directions 
of these novel technologies.
•	Ginkgo	BioWorks	has	an	engineering	platform	with	which	
it creates standardized microbes, or “biobricks,” for all kinds 
of industries, while simultaneously contributing to an open-
source registry of biological parts.
•	Protein	Sciences	uses	worm	cells	instead	of	chicken	eggs	in	
order to develop novel vaccines, and hopes to disrupt the vac-
cine market by being able to scale faster than older methods.
•	National	Aeronautics	and	Space	Administration	(NASA)	has	
been investigating alternative foods for a long time. Seaweed 
has great nutritional value, and several algae companies, 
including Aurora Algae, Blue Marble Biomaterials, and Sola-
zyme, are working on improving this value. Artificial meat 
grown in bioreactors is a very attractive commercial target.
•	At	the	Centre	for	Synthetic	Biology	and	Innovation	at	Impe-
rial College London, scientists are trying to feed pigeons a 
harmless lab-created microbe in order to make pigeon drop-
pings much more environmentally friendly—thereby saving 
cities’ considerable cleaning costs.
•	Under	the	title	Living	Foundries,	the	Defense	Advanced	Re-
search Projects Agency (DARPA) is experimenting with re-
pairing systems with the help of biology. Smart maintenance, 
indeed. One day, such technologies will be applied in disaster 
areas.
•	Sample6	Technologies	develops	sensors	that	detect	harmful	
bacteria in the food industry in real time. Future markets in-
clude healthcare, retail food chains, and water industries.
•	Along	with	several	 industrial	and	public	partners,	Codexis	
is developing microbial genomes (bio-catalyzers) with the 
capability to capture extraordinarily large amounts of carbon 
dioxide, in order to reduce emissions and costs and to be able 
to store carbon in alumina and fertilizer products. Imagine 
earning money from carbon dioxide!
•	With	the	introduction	of	a	tube	of	frozen,	synthetically	al-
tered microbes, Mars could be terraformed and colonized. 
Photosynthetic algae and bacteria would trigger the develop-
ment of a Martian habitable environment. Bacteria and syn-
thetic biology are the enablers of the colonization of other 
planets.
These vivid examples show the potential and scope of synthet-
ic biology. The following sections focus on the engineering foun-
dations of synthetic biology.
5.2. Virtual evolution
Code engineering in synthetic biology will lead to virtual, 
rapid, and often strange evolutions [5,6]. The structural analy-
ses of proteins will be made easier because we will be able to 
change proteins artificially. Clustered regularly interspaced short 
palindromic repeat (CRISPR), a recent innovation that enables 
alterations to any part of the DNA chromosomes without intro-
ducing unintended mutilations and flaws, and an advance made 
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Combinations of technologies with enzyme engineering (e.g., 
fermenting processes) will provide cost-efficient new basic ma-
terials for the pharmaceutical industries, and will also create 
new biofuels. Major insights into as yet unknown or undetected 
biological principles can be expected as a byproduct of these new 
analytical and synthetic methods.
Because of their high energy density, we still need carbon- 
based fuels. With the help of phototrophic or future heterotroph-
ic organisms—so-called bioreactors—second-generation biofuels 
will use the whole plant and not just 4% of it as is used today 
[9,10]. The production of oils and fatty acids might be genetically 
optimized at the molecular level, creating biodiesel and synthetic 
diesel. Photosynthetically active organisms will be used to pro-
duce isobutene and isoprene as bases for iso-octanes [11].
Through cloning and the combination of genetic groups, bac-
teria might be induced to produce and then secrete fatty acids in 
large quantities, as bioreactors. However, living cells will need to 
be kept stable and alive, despite these strong manipulations and 
interventions. We can expect a few bioreactor “meltdowns”!
6. Innovation and economic potential
In terms of turnover, industrial biotechnology as yet consti-
tutes only a one-digit percentage of the overall turnover of the 
chemical industry worldwide. Biofuels, enzymes, antibiotics, vita-
mins, and amino acids are some of its products, for applications 
such as medicine, human food, animal feed, detergents, and other 
industries.
In the near future, second-generation bio-products will sup-
plement classical methods of mutation and genetic selection. The 
new methods include metabolic engineering and system biology, 
that is, genetic changes in organisms, or the introduction of do-
nor genes from other organisms. New metabolisms will help to 
generate building blocks for new, specialized plastics. Artemisinin 
(against malaria), hydrocortisone, and penicillin will be produced 
in yeasts, provided that this can be done naturally, in relevant 
quantities, and at acceptable cost.
Interdisciplinary work will accelerate these changes. Bio- 
informatics and genome research are already strongly linked. 
Many more chemicals will be produced with biotechnology rath-
er than being extracted from the earth. New raw materials are 
emerging, such as the use of algae for photovoltaic coatings, in 
connection with light.
7. The heaven and hell of synthetic biology: Biosafety and 
biosecurity
Synthetic biology contains both “heaven,” in terms of opportu-
nities for a better world and untold benefits for humankind, and 
“hell,” in terms of opportunities and possibilities for misuse. To 
understand the implications inherent in this field, it is useful to 
order the developments within synthetic biology [1,12] from the 
known to the unknown (with examples).
•	Known:	DNA	synthesis,	with	the	characteristics	of	synthetic	
genes, artificial chromosomes, synthetic viruses, and the syn-
thesis of whole genomes;
•	Known:	bio-circuits,	with	genes,	bio-building	elements,	bi-
obricks, metabolic engineering (e.g., for medical drugs), and 
international competitions;
•	Current:	minimal	genomes,	involving	synthetic	top-down	bi-
ology, the reduction of the genomes of living organisms, and 
the exploitation of transport functions for genetic circuits;
•	Unknown:	protocells,	involving	alternative	biochemistry,	arti-
ficial phospholipids, cellular vehicles without key elements of 
life, synthetic cells, synthetic bottom-up biology, the produc-
tion of whole cells, and genetically engineered machines; and
•	Totally	unknown:	xeno	cells,	involving	alternative	biochem-
istry, XNA (“alien” life), unknown amino acids, the rearrange-
ment of genes, the development of new ribosomes, xeno 
organisms, and chemically modified organisms (CMOs).
Protocells, let alone xeno cells, are a possible source of infec-
tion. Once established in the environment, there are no adequate 
control mechanisms for these cells. National laws and interna-
tional agreements are meant to safeguard against the uninten-
tional liberation of new organisms. Scientists are agreed that a 
biological parallel world will have to be preserved in enclaves and 
protected by “genetic firewalls” [13].
Bioterrorists and developers of biological weapons may poten-
tially use synthetic biology. This particular threat is often known 
by the remarkable euphemism, “dual use.” In the past, there have 
been (benevolent) incidents of a deliberate increase in the viru-
lence of a cowpox strain, the emergence of a new infectious virus 
in the production of a polio virus genome, and the deliberate less-
ening of virulence in an inoculation drug against smallpox.
The 2004 A Synthetic Biohazard Non-Proliferation Proposal is 
in need of international updating. Open-source biotechnology 
makes it difficult to self-regulate the industry, or mitigate safety 
and security concerns.
In another discipline, computer science, we considered the 
threat of misuse to be irrelevant for a very long time. This author 
organized a mobile telephone security conference at a time when 
nobody thought mobile phones could be attacked, and the confer-
ence was a failure. Today, the overwhelming majority of Internet 
traffic is spam, mobile telephones are under attack, and the costs 
of Web security are rising rapidly. By analogy, I would argue that—
on top of an academic and public debate about the consequences 
of bionics and synthetic biology—we need much more radical, 
internationally agreed-on, and smart approaches to improve and 
maintain safety and security in the application of synthetic biol-
ogy. Do we need international biosecurity oversight institutions? 
Yes, with robust competencies!
In the US, biosecurity against malicious activity is a major con-
cern. The emphasis in Europe is on biosafety (safe research) and 
on engaging with the public. Are our current risk-management 
provisions sufficient? Probably not, in view of the unknown risks 
and potential military opportunities/threats from these technolo-
gies [14]. This author expects that self-destruct mechanisms will 
become an increasingly natural part of advanced synthetic biol-
ogy research and practice in order to mitigate accidents.
Advisory bodies for the German Bundestag are currently work-
ing on a policy document intended to mitigate synthetic biology 
risk.
8. Geostrategic shift
Bionics industries exist in many countries. However, synthetic 
biology has a much more uneven distribution, and, as an im-
portant engineering industry, has a relatively feeble presence in 
Germany, even if policy documents seem to indicate otherwise. In 
Holland, three major universities have agreed to pool resources. 
China, in particular, stands to gain due to its massive investment 
in the field and to a more relaxed regulatory environment. How-
ever, as we have seen with digitization, unexpected results occur 
as industrial paradigms unfold, and it is yet to be seen which 
countries will take a lead role in Industry 5.0, and which coun-
tries will benefit most.
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9. The necessity of an academic and public debate
From previous industrial paradigm shifts, we have—post hoc—
learned the necessity of an engaged academic and public dia-
logue. Industry 4.0 has already triggered a debate about what 
it will be like to live alongside robots in the future. Industry 5.0 
discussions touch on the very essence of humanity’s existence, 
physical integrity, and relationship with nature. At the moment, 
this debate seems theoretical, yet it will soon come to the fore.
As usual, technical advances are ahead of the public debates. 
A synthetic biology open language (SBOL) is already in place. 
The field is defined by engineers, and the benefits are couched 
in engineering terms; that is, engineered biological systems will 
process information, manipulate chemicals, fabricate materials 
and structures, produce energy, provide food, and maintain and 
enhance human health and our environment [10].
Important questions remain as to control of and access to the 
products, and who will benefit. Should we grant patents on liv-
ing organisms? How much bioengineering of human embryos is 
acceptable? How much biological retro-engineering of living hu-
mans can we afford or will we permit?
Through scenarios and case studies, we must create awareness 
of the implications of synthetic biology. As an interdisciplinary 
field, it needs to be integrated into many courses of studies. For 
example, the universities of Oxford, Bristol, and Warwick have 
founded a joint doctoral program that admits students from engi-
neering, biology, biochemistry, physics, plant sciences, chemistry, 
statistics, mathematics, and computing. In addition, synthetic biol-
ogy research should be developed with a global, open dialogue 
about the scientific, social, and economic implications, without 
shying away from a public debate about the ethical aspects of this 
emerging field.
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